TELA Bio, Inc. (TELA) Misses Q3 EPS by 2c

TELA Bio, Inc. (NASDAQ: TELA) reported Q3 EPS of ($0.64), $0.02 worse than the analyst estimate of ($0.62). Revenue for the quarter came in at $11.2 million versus the consensus estimate of $10.86 million.

For earnings history and earnings-related data on TELA Bio, Inc. (TELA) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• The LGL Group (LGL) Misses Q2 EPS by 8c
• BofA Securities Reiterates Buy Rating on Micron Technology (MU); Sees $230+ in EPS by FY30